鶹ý

Feature Channels: Diabetes

Filters close
Go to Advanced Search
Released: 28-Apr-2025 10:10 AM EDT
Digital Health Interventions to Prevent Type 2 Diabetes Mellitus: Systematic Review
Journal of Medical Internet Research

Background: Digital health interventions (DHIs) have rapidly evolved and significantly revolutionized the health care system. The quadruple aims of health care (improving population health, enhancing consumer experience, enhancing he...

Released: 28-Apr-2025 8:20 AM EDT
Drug Combination Reduces Breast Cancer Risk and Improves Metabolic Health in Rats
Michigan Medicine - University of Michigan

In a study published in JCI Insight, researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.

Released: 24-Apr-2025 10:45 AM EDT
Você tem hipotiroidismo? Especialista explica o diagnóstico e o que isso significa
Mayo Clinic

JACKSONVILLE, Flórida — Você tem se sentido cansado e ganhou peso. Pode ser apenas um sinal de que você está envelhecendo, mas pode haver uma chance de que esses sintomas gerais sejam causados pelo hipotiroidismo. O Dr. Victor Bernet, endocrinologista na Mayo Clinic, explica os fatores de risco e como essa condição é diagnosticada e tratada.

Released: 24-Apr-2025 10:30 AM EDT
Do You Have Hypothyroidism? Expert Explains Diagnosis, What It Means
Mayo Clinic

JACKSONVILLE, Florida — You've been feeling fatigued and have gained some weight. It could be just a sign that you're getting older, but these symptoms might be caused by hypothyroidism. Victor Bernet, M.D., an endocrinologist at Mayo Clinic, explains risk factors and how the condition is diagnosed and treated.

Released: 24-Apr-2025 9:45 AM EDT
¿Tiene hipotiroidismo? Experto explica el diagnóstico y lo qué significa
Mayo Clinic

JACKSONVILLE, Florida — Usted se ha estado sintiendo cansado y ha ganado peso. Puede ser solo una señal de que está envejeciendo, pero puede haber una posibilidad de que estos síntomas generales sean causados por hipotiroidismo. El Dr. Victor Bernet, endocrinólogo en Mayo Clinic, explica los factores de riesgo y cómo se diagnostica y trata esta afección.

Released: 24-Apr-2025 12:05 AM EDT
هل أنت مصاب بقصور الدرقية؟ يشرح الخبراء التشخيص وما يعنيه
Mayo Clinic

جاكسونفيل، ولاية فلوريدا —منذ فترة وأنت تشعر بالتعب كما أنك اكتسبت بعض الوزن. قد يكون ذلك مجرد علامة على أنك تتقدم بالعمر، ولكن هناك احتمال أن يكون سبب هذه الأعراض العامة هو قصور الدرقية. يشرح فيكتور بيرنت، دكتور في الطب اختصاصي الغدد الصماء في مايو كلينك عوامل الخطورة وكيفية تشخيص الحالة وعلاجها.

鶹ý: Online Tool Tests How Taxes Affect Sugar-Sweetened Drink Purchases
Released: 23-Apr-2025 6:45 PM EDT
Online Tool Tests How Taxes Affect Sugar-Sweetened Drink Purchases
Virginia Tech

Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC created the Experimental Beverage Marketplace to test the potential effects of these tax proposals on purchasing and consumption. Its purpose is to ensure that policy is guided by evidence.

     
Released: 22-Apr-2025 7:55 PM EDT
Nudge Boosts Statin-Prescribing, Means Fewer Pharmacy Trips
Perelman School of Medicine at the University of Pennsylvania

Statins are lifesaving to those with high cholesterol, but patients don’t always take them. A nudge that increased long-term prescriptions could be key

Not for public release

This news release is embargoed until 21-Apr-2025 5:00 PM EDT Released to reporters: 15-Apr-2025 7:45 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Apr-2025 5:00 PM EDT The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

鶹ý: Monell Center Study Identifies GLP-1 Therapies as a Possible Treatment for Rare Genetic Disorder Bardet-Biedl Syndrome
Released: 17-Apr-2025 8:45 PM EDT
Monell Center Study Identifies GLP-1 Therapies as a Possible Treatment for Rare Genetic Disorder Bardet-Biedl Syndrome
Monell Chemical Senses Center

Monell Center investigators identified that GLP-1R agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as a promising therapeutic for managing the metabolic complications associated with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments. They used a genetically engineered mouse model of BBS that displayed the hallmark features of the condition.

Released: 15-Apr-2025 7:30 PM EDT
Studying Interventions to Help Type 2 Diabetes Patients Avoid Hospitalizations
Michigan Medicine - University of Michigan

Social determinants of health can have a large impact on the health of people living with type 2 diabetes

Not for public release

This news release is embargoed until 14-Apr-2025 5:00 PM EDT Released to reporters: 8-Apr-2025 9:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Apr-2025 5:00 PM EDT The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

鶹ý: Neonatal Diabetes Model Provides Insights on How Condition Develops
Released: 8-Apr-2025 7:10 PM EDT
Neonatal Diabetes Model Provides Insights on How Condition Develops
UT Southwestern Medical Center

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes suggests the condition stems from gradual damage to the pancreas through misregulation of a molecular pathway called the unfolded protein response (UPR). The findings, published in Molecular Metabolism, could one day lead to new ways to treat more common subsets of diabetes, including Types 1 and 2, which affect hundreds of millions worldwide.

鶹ý: Einstein Research Leads to Designation of New Type of Diabetes
Released: 8-Apr-2025 3:00 PM EDT
Einstein Research Leads to Designation of New Type of Diabetes
Albert Einstein College of Medicine

Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now officially recognized as a distinct form of the disease, known as type 5 diabetes.

Released: 7-Apr-2025 2:45 PM EDT
Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Not for public release

This news release is embargoed until 4-Apr-2025 10:00 AM EDT Released to reporters: 4-Apr-2025 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Apr-2025 10:00 AM EDT The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 4-Apr-2025 10:00 AM EDT Released to reporters: 31-Mar-2025 7:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Apr-2025 10:00 AM EDT The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

鶹ý: Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit
Released: 3-Apr-2025 7:00 AM EDT
Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit
American Physiological Society (APS)

Nobel Laureate James Rothman, PhD; Holly A. Ingraham, PhD, FASEB’s 2024 Lifetime Achievement awardee; and George A. Brooks, PhD, FAPS, the American Physiological Society’s (APS) 2025 Walter Cannon Award recipient, are among the highlighted speakers who will attend the American Physiology Summit. The Summit, APS’ flagship annual meeting, will be held April 24–27 in Baltimore.

鶹ý: Hackensack Meridian Pascack Valley Medical Group Welcomes Dr. Carolyn Mudry
Released: 1-Apr-2025 9:00 AM EDT
Hackensack Meridian Pascack Valley Medical Group Welcomes Dr. Carolyn Mudry
Hackensack Meridian Pascack Valley Medical Center

We’re pleased to announce Carolyn Mudry, D.O, has joined the Pascack Valley Medical Group family. With over 25 years of experience, Dr. Mudry brings a wealth of expertise in providing comprehensive, patient-centered care to the patients of Pascack Valley.

鶹ý: Antibiotics Exposure in Infancy May Boost Diabetes Risk
Released: 31-Mar-2025 5:55 PM EDT
Antibiotics Exposure in Infancy May Boost Diabetes Risk
University of Colorado Boulder

Exposure to antibiotics during infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life. The findings shine a light on the importance of the infant microbiome and could lead to new approaches for addressing metabolic diseases.



close
3.93309